Vaccines & Infection
Closely linked with the region's biomanufacturing strength is expertise in vaccines and anti-infectious disease.
Liverpool School of Tropical Medicine is the oldest such school in the world. LSTM is an international postgraduate centre of excellence, devoted to research, education and training, and consultancy. LSTM has a portfolio of research based in the developing countries of the tropics. This is run alongside laboratory-based programmes, particularly in the area of parasitic and other communicable diseases.
Novartis Vaccines in Speke manufactures an extensive range of products including: Begrivac™, the first preservative-free vaccine; Encepur™, a vaccine against tick-borne encephalitis; and Fluvirin™, a triple-antigen flu vaccine, approved for sale in more than 20 countries.
MedImmune in Speke is focused on using biotechnology to produce innovative products and this site provides a significant volume of their biomanufacturing capability for Flumist™.
Neutec Pharma in Manchester is a biopharmaceutical company, which specialises in the development of genetically recombinant antibodies, or "grabs", for the treatment of life-threatening infections. NeuTec's two leading drug candidates are Mycograb®, which targets systemic candidiasis, and Aurograb®, which targets Staphylococcus aureus including methicillin-resistant Staphylococcus aureus ("MRSA").
Protherics in Cheshire. This research and development site focuses on bio-therapeutics with products such as Crofab™, to treat snakebites.
